Complete remission through icotinib treatment in Non-small cell lung cancer epidermal growth factor receptor mutation patient with brain metastasis: A case report

由 Wang, Tao, Wang, Ruimin, Dong, Zhouhuan, Liang, Naichao, Chang, Ping
發表在 Open Med (Wars) (2016)

Patients with advanced non-small cell lung cancer with EGFR mutations in addition to complex mutations treated with osimertinib have a poor clinical outcome: A real-world data anal...

由 Chang, Nijia, Duan, Jingjing, Wang, Lingxiong, Dong, Zhouhuan, Liu, Zhefeng
發表在 Oncol Lett (2020)

Effects of icotinib on early-stage non-small-cell lung cancer as neoadjuvant treatment with different epidermal growth factor receptor phenotypes

由 Wang, Tao, Liu, Yang, Zhou, Bin, Wang, Zhi, Liang, Naichao, Zhang, Yundong, Dong, Zhouhuan, Li, Jie
發表在 Onco Targets Ther (2016)

Somatic mutation profiling and HER2 status in KRAS-positive Chinese colorectal cancer patients

由 Dong, Zhouhuan, Kong, Linghong, Wan, Zhiyi, Zhu, Fengwei, Zhong, Mei, Lv, Yali, Zhao, Po, Shi, Huaiyin
發表在 Sci Rep (2019)

GLI1 activation is a key mechanism of erlotinib resistance in human non-small cell lung cancer

由 Dong, Zhouhuan, Wang, Yun, Ding, Vivianne, Yan, Xiang, Lv, Yali, Zhong, Mei, Zhu, Fengwei, Zhao, Po, He, Charlotte, Ding, Feng, Shi, Huaiyin
發表在 Oncol Lett (2020)

The different expression of glycogen phosphorylases in renal clear cell renal carcinoma and chromophobe renal carcinoma

由 Lu, Yang, Luo, Guangda, Zhu, Songbiao, Wang, Xu, Chen, Yuling, Dong, ZhouHuan, Wang, Shiyu, Ma, Jie, Deng, Haiteng, Wu, Di, Dong, Jun
發表在 Clin Proteomics (2020)

Catalog of Lung Cancer Gene Mutations Among Chinese Patients

由 Xue, Xinying, Asuquo, Idorenyin, Hong, Lei, Gao, Jie, Dong, Zhouhuan, Pang, Li, Jiang, Tianjiao, Meng, Mingming, Fan, Jingbo, Wen, Jiaxin, Deng, Hui, Zang, Xuelei, Ma, Xidong, Guo, Rui, Qin, Chong, Meng, Yao, Ma, Heji, Han, Jun, Wang, Haijiao, Xue, Zhiqiang, Zhao, Dahai, Lin, Dongliang, Pan, Lei
發表在 Front Oncol (2020)